现代肿瘤医学
現代腫瘤醫學
현대종류의학
Journal of Modern Oncology
2015年
21期
3154-3157
,共4页
邵国益%张献%胡根%戴丽强
邵國益%張獻%鬍根%戴麗彊
소국익%장헌%호근%대려강
胃肝样腺癌%血清AFP%临床分析
胃肝樣腺癌%血清AFP%臨床分析
위간양선암%혈청AFP%림상분석
hepatoid adenocarcinoma of stomach,serum AFP%clinical analysis
目的:探讨胃肝样腺癌患者的治疗以及预后,同时分析血清甲胎蛋白在诊断胃肝样腺癌及判断预后中的临床意义。方法:分析15例手术病理证实为胃肝样腺癌患者的临床资料。结果:15例患者,生存时间3.1~24个月,平均10.52个月,术前血清AFP浓度范围为25.23~13500μg/L。结论:胃肝样腺癌AFP 水平波动范围大,血清AFP 升高是胃肝样腺癌重要的临床病理特点,在胃肝样腺癌诊治中具有重要价值,可作为早期诊断的条件之一,同时可以用于监测肿瘤复发与转移。胃肝样腺癌预后极差,合并肝转移或者门静脉癌栓患者建议避免手术治疗。
目的:探討胃肝樣腺癌患者的治療以及預後,同時分析血清甲胎蛋白在診斷胃肝樣腺癌及判斷預後中的臨床意義。方法:分析15例手術病理證實為胃肝樣腺癌患者的臨床資料。結果:15例患者,生存時間3.1~24箇月,平均10.52箇月,術前血清AFP濃度範圍為25.23~13500μg/L。結論:胃肝樣腺癌AFP 水平波動範圍大,血清AFP 升高是胃肝樣腺癌重要的臨床病理特點,在胃肝樣腺癌診治中具有重要價值,可作為早期診斷的條件之一,同時可以用于鑑測腫瘤複髮與轉移。胃肝樣腺癌預後極差,閤併肝轉移或者門靜脈癌栓患者建議避免手術治療。
목적:탐토위간양선암환자적치료이급예후,동시분석혈청갑태단백재진단위간양선암급판단예후중적림상의의。방법:분석15례수술병리증실위위간양선암환자적림상자료。결과:15례환자,생존시간3.1~24개월,평균10.52개월,술전혈청AFP농도범위위25.23~13500μg/L。결론:위간양선암AFP 수평파동범위대,혈청AFP 승고시위간양선암중요적림상병리특점,재위간양선암진치중구유중요개치,가작위조기진단적조건지일,동시가이용우감측종류복발여전이。위간양선암예후겁차,합병간전이혹자문정맥암전환자건의피면수술치료。
Objective:To investigate the treatment and prognosis of the hepatoid adenocarcinoma of the stomach ( HAS),and analyze serum alpha fetoprotein( AFP)clinical significance of HAS in diagnosis and prognosis. Meth-ods:Collected 15 cases of pathologically confirmed HAS with positive AFP. Results:The survival time of all 1 5 pa-tients was 3 . 1 ~2 4 months ,the average was 1 0 . 5 2 months . Serum AFP concentrations ranged from 2 5 . 2 3 to 13 500μg/L. Conclusion:AFP level of HAS fluctuate widely. And elevate AFP is an important clinical and pathologi-cal feature of HAS. It is very useful for the diagnosis and treatment of HAS. Its useful for the early diagnosis and moni-tor of recurrence and metastasis of tumor. The prognosis of HAS is very poor,especially for patients with liver metasta-sis or portal vein tumor thrombus. We should avoid operations for metastasis cases.